Analytical Data
-
Gene name
TDH
- Application
-
Alternative Names
SDR14E1P; Short Chain Dehydrogenase/Reductase Family 14E,Member 1; Inactive L-threonine 3-dehydrogenase, mitochondrial
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IZJ6
-
Expression Region
Met1~Cys229
-
Molecular Weight
55.3kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of TDH (Thioredoxin-like protein) recombinant proteins has gained significant attention due to their crucial role in various biological processes and potential applications in biotechnology and medicine. TDH proteins are known for their ability to facilitate redox reactions, thereby participating in cellular stress responses, protein folding, and regulation of apoptosis. The therapeutic potential of TDH proteins in treating diseases, including cancer and neurodegenerative disorders, has prompted researchers to explore their functions and mechanisms. Recombinant DNA technology allows for the production of large quantities of pure TDH proteins, enabling detailed biochemical and structural studies. Furthermore, the engineering of TDH proteins for enhanced stability and activity has opened new avenues in enzyme biotechnology and biosensors. As a result, TDH recombinant proteins are being investigated for their utility in drug development, diagnostics, and as therapeutic agents, making them a focal point of research in both fundamental biology and applied sciences.
